BRD4-mediated repression of p53 is a target for combination therapy in AML.

Nat Commun · 2021 · PMC7801601 · PMID 33431824

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The majority of the samples showed a trend towards greater than additive killing by the combination (x axis < 1), compared to the single drugs (Fig. 1b ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.